Prescription drug · ANDA
Klor-Con (Potassium chloride) NDC 0245-0835
Potassium chloride 600 mg/1 · Tablet, Film coated, Extended release · Oral · Upsher-Smith Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0245-0835-01 | 0024508350100245083501 | 10 BLISTER PACK in 1 CARTON (0245-0835-01) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Feb 25, 2026 | |
| 0245-0835-11 | 0024508351100245083511 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-0835-11)Marketed from Aug 15, 2025 | |
| 0245-0835-15 | 0024508351500245083515 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-0835-15)Marketed from Aug 15, 2025 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Klor-Con
- Generic name (nonproprietary)
- potassium chloride
- Active ingredients
- Potassium chloride — 600 mg/1
- Dosage form
- Tablet, Film coated, Extended release
- Route
- Oral
- Labeler
- Upsher-Smith Laboratories, LLCNDC labeler code 0245
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218979
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 0245-0835_363df849-ee37-4c58-9ef9-2b59d3d49f0bSPL ID 363df849-ee37-4c58-9ef9-2b59d3d49f0b
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400245083501followed by a unit qualifier and the quantityPackage 00245-0835-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0245-0835
- What is NDC 0245-0835?
- 0245-0835 is the product NDC for Klor-Con (potassium chloride), Potassium chloride 600 mg/1 tablet, film coated, extended release, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Klor-Con (Potassium chloride).
- What is the active ingredient?
- Potassium chloride.
- Who is the labeler?
- Upsher-Smith Laboratories, LLC, NDC labeler code 0245. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Klor-Con?
- 4 other product NDCs are listed under this name. See all Klor-Con NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Klor-Con products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Klor-Conpotassium chloride | Potassium chloride 750 mg/1 | Tablet, Film coated, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0245-0836 | 00245-0836-0100245-0836-1100245-0836-15 |
| Klor-Conpotassium chloride | Potassium chloride 1.5 g/1 | Powder, For solutionOral | Upsher-Smith Laboratories, LLC | 0245-0360 | 00245-0360-0100245-0360-30 |
| Klor-Conpotassium chloride | Potassium chloride 600 mg/1 | Tablet, Film coated, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0245-5315 | 00245-5315-0100245-5315-1100245-5315-15 |
| Klor-Conpotassium chloride | Potassium chloride 750 mg/1 | Tablet, Film coated, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0245-5316 | 00245-5316-0100245-5316-1100245-5316-15 |
Other NDCs under ANDA 218979
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Klor-Conpotassium chloride | Potassium chloride 750 mg/1 | Tablet, Film coated, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0245-0836 |
| Potassium Chloride | Potassium chloride 600 mg/1 | Tablet, Extended releaseOral | Upsher-Smith Laboratories, LLC | 24979-229 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | Upsher-Smith Laboratories, LLC | 24979-230 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | AvKARE | 42291-487 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-977 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | Northwind Health Company, LLC | 82868-111 |